#covidprofiteering #covidendgame
#European #ombudsman, Emily O'Reilly, said that the unanswered questions about private talks in one of the largest #public #tenders in history of #EuropeanUnion held between president of #EuropeanCommission #UrsulavonderLeyen and #Pfizer boss #AlbertBourla won't go away.
'We need to hear what went on, otherwise it’s going to drag on,' she said, citing lack of trust.
Lots of details, context, here: https://grabancijas.com/pucka-pravobraniteljica-tajni-razgovori-von-der-leyen-o-javnom-tenderu-za-cjepiva-nece-nestati/
#covidprofiteering #covidendgame #european #ombudsman #public #tenders #europeanunion #europeancommission #ursulavonderleyen #pfizer #albertbourla
#Pfizer CEO #AlbertBourla claimed at a news event last week that the company's #COVID-19 #vaccines will continue to be "free to all Americans," despite the company's plan to raise the price of the vaccine roughly 400%—a price difference that will be picked up by health insurers.
In Oct Pfizer said that it plans to raise the price of a dose of its vaccine from about $30 to somewhere between $110-$130 as it moves the shots to the commercial market next year.
#USHealthCare
https://arstechnica.com/science/2022/11/covid-vaccines-will-still-be-free-despite-400-price-hike-pfizer-ceo-says/
#pfizer #albertbourla #covid #vaccines #ushealthcare
#Pfizer CEO #AlbertBourla claimed at a news event that the company's #COVID-19 #vaccines will continue to be "free to all Americans," despite the company's plan to raise the price of the vaccine roughly 400%—a price difference that will be picked up by health insurers.
In Oct Pfizer said that it plans to raise the price of a dose of its vaccine from about $30 to somewhere between $110-$130 as it moves the shots to the commercial market next year.
#USHealthCare
https://arstechnica.com/science/2022/11/covid-vaccines-will-still-be-free-despite-400-price-hike-pfizer-ceo-says/
#pfizer #albertbourla #covid #vaccines #ushealthcare